	US 12,090,137 B2
	Solid Δ⁹-tetrahydrocannabinol (Δ⁹-THC) compositions
Emily Rigsbee, Lafayette, IN (US); David T. Jonaitis, Brookston, IN (US); Nathan Schultheiss, West Lafayette, IN (US); and Lloyd Steven Miller, Indianapolis, IN (US)
Assigned to CANNA CHEMISTRIES LLC, Vincennes, IN (US)
Filed by CANNA-CHEMISTRIES LLC, Vincennes, IN (US)
Filed on Aug. 25, 2022, as Appl. No. 17/895,347.
Application 17/895,347 is a continuation of application No. 17/575,035, filed on Jan. 13, 2022, granted, now 11,478,447.
Application 17/575,035 is a continuation of application No. PCT/US2021/041992, filed on Jul. 16, 2021.
Claims priority of provisional application 63/053,205, filed on Jul. 17, 2020.
Claims priority of provisional application 63/154,151, filed on Feb. 26, 2021.
Claims priority of provisional application 63/154,153, filed on Feb. 26, 2021.
Prior Publication US 2022/0409572 A1, Dec. 29, 2022
Int. Cl. A61K 9/19 (2006.01); A23L 27/30 (2016.01); A23L 33/105 (2016.01); A61K 9/16 (2006.01); A61K 31/00 (2006.01); A61K 31/352 (2006.01); A61K 33/00 (2006.01)

CPC A61K 31/352 (2013.01) [A23L 27/33 (2016.08); A23L 33/105 (2016.08); A61K 9/1617 (2013.01); A61K 9/19 (2013.01); A23V 2002/00 (2013.01)]

14 Claims

1. A solid Δ⁹-THC composition comprising Δ⁹-tetrahydrocannabinol (THC) and a powder former and having a molar ratio of Δ⁹-THC to powder former to form a flowable Δ⁹-THC powder and wherein the powder former is β-nicotinamide adenine dinucleotide and epigallocatechin gallate.